10 February 2022

Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

On 9 February 2022, the Luxembourg Parliament has approved a new law amending the law of 22 March 2004 on securitisation. The new law will enter into force after publication in the official journal, which should occur in the course of February.

The new legislation has successfully implemented the feedback from market participants. Although the Luxembourg legal framework has proven so far to be sound and well-functioning, the new framework can even further increase the number of securitisation transactions using Luxembourg vehicles. Key changes include the diversification of financing instruments, active management of CDOs/CLOs and adjustments to the corporate governance of the securitisation framework.

The GSK Update provides a detailed overview of the new legal framework.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 12.02.2024

    GSK Update: ESG regulation – an outlook on developments for the year 2024

    Read more
  • 12.02.2024

    GSK Update: Green securitisations under the new Europe-an Green Bonds Regulation

    Read more
  • 11.09.2023

    GSK Update: Application of the law on a national screening mechanism for foreign direct investments in Luxembourg

    Read more
Contact person

Andreas Heinzmann, LL.M. eur.

Partner

+352 271802-30

andreas.heinzmann@gsk-lux.com

Valerio Scollo, LL.M. (NYU), LL.M. (NUS)

Partner

+352 271802-32

valerio.scollo@gsk-lux.com

Dr. Manuel Fernandez

Partner

+352 271802-31

manuel.fernandez@gsk-lux.com

© GSK Stockmann 2024